サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1415298

ポストバイオティクス市場：形態、タイプ、用途、流通チャネル別-2024～2030年の世界予測

Postbiotics Market by Form (Liquid, Powder), Type (Bacterial Lysates, Cell Wall Fragments, Cell-Free Supernatants), Application, Distribution Channel - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 186 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ポストバイオティクス市場：形態、タイプ、用途、流通チャネル別-2024～2030年の世界予測
出版日: 2024年01月16日
発行: 360iResearch
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ポストバイオティクス市場規模は2023年に19億7,000万米ドルと推定され、2024年には21億米ドルに達し、CAGR 7.21%で2030年には32億1,000万米ドルに達すると予測されます。

ポストバイオティクスの世界市場

主要市場の統計
基準年[2023年] 19億7,000万米ドル
予測年[2024年] 21億米ドル
予測年[2030年] 32億1,000万米ドル
CAGR（%） 7.21%
ポストバイオティクス Market-IMG1

市場情勢は、プロバイオティクス細菌の無生物から得られる製品の商業的展望を構成します。この市場には、プロバイオティクス細菌の溶解後に放出される代謝産物、細胞壁断片、機能性タンパク質など、あるいは発酵過程で生成される様々な物質が含まれます。これらの物質は、保存中や使用中に生菌を維持する複雑さを伴うことなく、生きたプロバイオティクスが提供するものと同様、あるいはそれ以上の健康上のメリットをもたらす能力を持っているとして注目を集めています。応用面では、ポストバイオティクスは栄養補助食品、医薬品、機能性食品や飲食品に利用され、主に腸内健康効果、免疫系強化、抗炎症作用が期待されています。ポストバイオティクスを多く取り入れている最終用途産業には、医療、飲食品、パーソナルケア、動物飼料分野が含まれます。腸内マイクロバイオーム管理と予防的医療対策への関心の高まりは、ポストバイオティクスの応用範囲に大きな影響を与えています。ポストバイオティクス市場の範囲は、その利点を強調する調査や、発酵と下流処理技術の技術的進歩の増加とともに拡大しています。

地域別洞察

米国では、ポストバイオティクスの需要は、科学的に検証された健康製品を好む傾向にあり、ポストバイオティクス生産の最適化に焦点を当てた研究投資や特許件数の増加に反映されています。同様にカナダも、消費者がナチュラルでクリーンラベルの原料に惹かれ、政府も民間もポストバイオティクス研究に積極的に資金を提供しており、市場は拡大しています。欧州連合（EU）は、科学的裏付けのある製品開発を促進する厳格な健康強調表示規制によって支えられており、ポストバイオティクスの技術革新をリードしています。中東での関心の高まりとアフリカ全域での緩やかな市場成長は、ポストバイオティクスの潜在的な健康効果に対する認識が高まっていることを示しています。アジア太平洋諸国、特に中国、日本、インドは、健康志向の消費者、大規模な研究投資、栄養補助食品への受容性により、力強い市場成長の可能性を示しています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは、ポストバイオティクス市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、ポストバイオティクス市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています。

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています。

1-ポストバイオティクス市場の市場規模と予測は？

2-ポストバイオティクス市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-ポストバイオティクス市場における技術動向と規制の枠組みは？

4-ポストバイオティクス市場における主要ベンダーの市場シェアは？

5-ポストバイオティクス市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 医療従事者と消費者の間でのポストバイオティクスの健康上の利点の認識
      • 世界中でナチュラルラベルのサプリメント製品が好まれている
      • インスタント飲食品におけるポストバイオティクスの利用
    • 抑制要因
      • ポストバイオティクス製品の有害なリコール
    • 機会
      • ポストバイオティクス製品の配合・製造技術の進歩
      • 栄養分野で乳製品以外のポストバイオティクスの人気が高まる
    • 課題
      • ポストバイオティクスの標準化と品質維持の複雑さ
  • 市場セグメンテーション分析
    • 形態：液体のポストバイオティクスは即時使用を対象としており、すぐに飲める形式で提供されており、エンドユーザーにとって非常に便利
    • タイプ：細菌溶解物は免疫応答の強化に非常に有益である傾向がある
    • 用途：顧客は、成長と健康上の成果における栄養上の利点に関する規制基準に沿ったポストバイオティクスを好む傾向がある
    • 流通チャネル：消費者直販のポストバイオティクス製品は、eコマースオンラインプラットフォームを通じて引き続き急速に注目を集めている
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 ポストバイオティクス市場：形態別

  • イントロダクション
  • 液体
  • 粉末

第7章 ポストバイオティクス市場：タイプ別

  • イントロダクション
  • 細菌溶解物
  • 細胞壁の断片
  • 無細胞上清
  • 酵素
  • エキソ多糖類
  • リポ多糖類
  • 短鎖脂肪酸
  • ビタミンとアミノ酸

第8章 ポストバイオティクス市場：用途別

  • イントロダクション
  • 動物用飼料
  • 飲食品
  • パーソナルケアと化粧品
  • 医薬品

第9章 ポストバイオティクス市場：流通チャネル別

  • イントロダクション
  • オフライン
  • オンライン

第10章 南北アメリカのポストバイオティクス市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋のポストバイオティクス市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのポストバイオティクス市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 新製品発売と機能強化

第14章 競合ポートフォリオ

  • 主要な企業プロファイル
    • Archer-Daniels-Midland Company
    • Beekeepers Naturals Inc.
    • Bioflag Group
    • Cargill Incorporated
    • Dr. Emil Nutrition
    • DSM-Firmenich AG
    • Essential Formulas Incorporated
    • GeneFerm Biotechnology Co., Ltd.
    • Gundry MD
    • GutArmor by Get Wellness, LLC
    • Healist Naturals, Inc
    • Ildong Pharmaceutical Co., Ltd.
    • Kerry Group PLC
    • Kirin Holdings Company, Limited
    • Lactobio A/S
    • Maypro Group
    • MCLS Europe B.V.
    • MRM Nutrition
    • Otemchi Biotechnologies Pte. Ltd.
    • Phileo by Lesaffre
    • Postbiotics Inc.
    • Probiotics Australia Pty., Ltd.
    • Probioway Co., Ltd.
    • Sabinsa Corporation
    • Silab
    • Symbiotec Laboratoire
    • T.H.T. sa
    • woresan GmbH
    • POSTBIOTICA S.R.L.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. POSTBIOTICS MARKET RESEARCH PROCESS
  • FIGURE 2. POSTBIOTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. POSTBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. POSTBIOTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. POSTBIOTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. POSTBIOTICS MARKET DYNAMICS
  • FIGURE 7. POSTBIOTICS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 8. POSTBIOTICS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. POSTBIOTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. POSTBIOTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. POSTBIOTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. POSTBIOTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES POSTBIOTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES POSTBIOTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. POSTBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. POSTBIOTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. POSTBIOTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. POSTBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POSTBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 6. POSTBIOTICS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. POSTBIOTICS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. POSTBIOTICS MARKET SIZE, BY BACTERIAL LYSATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. POSTBIOTICS MARKET SIZE, BY CELL WALL FRAGMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. POSTBIOTICS MARKET SIZE, BY CELL-FREE SUPERNATANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. POSTBIOTICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. POSTBIOTICS MARKET SIZE, BY EXOPOLYSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. POSTBIOTICS MARKET SIZE, BY LIPOPOLYSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. POSTBIOTICS MARKET SIZE, BY SHORT-CHAIN FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. POSTBIOTICS MARKET SIZE, BY VITAMINS & AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. POSTBIOTICS MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. POSTBIOTICS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. POSTBIOTICS MARKET SIZE, BY PERSONAL CARE & COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. POSTBIOTICS MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. POSTBIOTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. POSTBIOTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES POSTBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA POSTBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM POSTBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM POSTBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM POSTBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM POSTBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. POSTBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 194. POSTBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. POSTBIOTICS MARKET LICENSE & PRICING
目次
Product Code: MRR-144C638C925E

[186 Pages Report] The Postbiotics Market size was estimated at USD 1.97 billion in 2023 and expected to reach USD 2.10 billion in 2024, at a CAGR 7.21% to reach USD 3.21 billion by 2030.

Global Postbiotics Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.97 billion
Estimated Year [2024] USD 2.10 billion
Forecast Year [2030] USD 3.21 billion
CAGR (%) 7.21%
Postbiotics Market - IMG1

The postbiotics market comprises the commercial landscape for products derived from the inanimate matter of probiotic bacteria. It includes various substances such as metabolites, cell-wall fragments, and functional proteins released after the lysis of probiotic bacteria or produced during the fermentation process. These substances have been gaining attention for their ability to confer health benefits similar to or even beyond those offered by live probiotics without the complexity of maintaining viability during storage and use. In terms of application, postbiotics are utilized in dietary supplements, pharmaceuticals, and functional foods and beverages, primarily for their gut health benefits, immune system enhancement, and anti-inflammatory properties. The end-use industries that largely incorporate postbiotics include healthcare, food & beverage, personal care, and animal feed sectors. The growing interest in gut microbiome management and preventative healthcare measures substantially influences the postbiotics application spectrum. The scope of the postbiotics market is expanding with growing research highlighting their benefits and technological advancements in fermentation and downstream processing techniques.

Regional Insights

In the USA, demand for postbiotic is buoyed by a preference for scientifically validated health products, reflected in research investments and a rising number of patents focused on optimizing postbiotic production. Similarly, Canada's market is expanding, with consumers gravitating towards natural, clean-label ingredients, and both governmental and private sectors actively funding postbiotic research. The European Union leads in postbiotic innovation, upheld by stringent health claim regulations that promote scientifically backed product development. The burgeoning interest in the Middle East and gradual market growth throughout Africa indicate a rising acknowledgment of postbiotics' potential health benefits. Asia Pacific countries, particularly China, Japan, and India, are showing strong market growth potential, driven by health-conscious consumers, significant research investments, and a receptiveness to dietary supplements.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Postbiotics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Postbiotics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Postbiotics Market, highlighting leading vendors and their innovative profiles. These include Archer-Daniels-Midland Company, Beekeepers Naturals Inc., Bioflag Group, Cargill Incorporated, Dr. Emil Nutrition, DSM-Firmenich AG, Essential Formulas Incorporated, GeneFerm Biotechnology Co., Ltd., Gundry MD, GutArmor by Get Wellness, LLC, Healist Naturals, Inc, Ildong Pharmaceutical Co., Ltd., Kerry Group PLC, Kirin Holdings Company, Limited, Lactobio A/S, Maypro Group, MCLS Europe B.V., MRM Nutrition, Otemchi Biotechnologies Pte. Ltd., Phileo by Lesaffre, Postbiotics Inc., Probiotics Australia Pty., Ltd., Probioway Co., Ltd., Sabinsa Corporation, Silab, Symbiotec Laboratoire, T.H.T. sa, woresan GmbH, and POSTBIOTICA S.R.L..

Market Segmentation & Coverage

This research report categorizes the Postbiotics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Form
    • Liquid
    • Powder
  • Type
    • Bacterial Lysates
    • Cell Wall Fragments
    • Cell-Free Supernatants
    • Enzymes
    • Exopolysaccharides
    • Lipopolysaccharides
    • Short-Chain Fatty Acids
    • Vitamins & Amino Acids
  • Application
    • Animal Feed
    • Food & Beverage
    • Personal Care & Cosmetics
    • Pharmaceuticals
  • Distribution Channel
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Postbiotics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Postbiotics Market?

3. What are the technology trends and regulatory frameworks in the Postbiotics Market?

4. What is the market share of the leading vendors in the Postbiotics Market?

5. Which modes and strategic moves are suitable for entering the Postbiotics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Postbiotics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Awareness of health benefits of postbiotics among healthcare professionals and consumers
      • 5.1.1.2. Preference for natural and clean-label supplement products worldwide
      • 5.1.1.3. Utilization of postbiotics in convenience food and beverages
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse recalls of postbiotic products
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in formulation and production technologies of postbiotic products
      • 5.1.3.2. Rising popularity of non-dairy postbiotics in nutrition
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in standardization and quality maintenance of postbiotics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Form: Liquid postbiotics target immediate use and are presented in ready-to-drink formats, which are highly convenient for the end-user
    • 5.2.2. Type: Bacterial lysates tend to be immensely beneficial for enhanced immune responses
    • 5.2.3. Application: Customers tend to prefer postbiotics that align with regulatory standards for nutritional benefits in growth and health outcomes
    • 5.2.4. Distribution Channel: Direct-to-consumer postbiotic product remain quickly gained traction through its e-commerce online platform
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Postbiotics Market, by Form

  • 6.1. Introduction
  • 6.2. Liquid
  • 6.3. Powder

7. Postbiotics Market, by Type

  • 7.1. Introduction
  • 7.2. Bacterial Lysates
  • 7.3. Cell Wall Fragments
  • 7.4. Cell-Free Supernatants
  • 7.5. Enzymes
  • 7.6. Exopolysaccharides
  • 7.7. Lipopolysaccharides
  • 7.8. Short-Chain Fatty Acids
  • 7.9. Vitamins & Amino Acids

8. Postbiotics Market, by Application

  • 8.1. Introduction
  • 8.2. Animal Feed
  • 8.3. Food & Beverage
  • 8.4. Personal Care & Cosmetics
  • 8.5. Pharmaceuticals

9. Postbiotics Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Americas Postbiotics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Postbiotics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Postbiotics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. New Product Launch & Enhancement
      • 13.3.1.1. Tetra Pak and AB Biotek Introduce New Opportunities for Postbiotic Food and Drinks
      • 13.3.1.2. Dsm-Firmenich Set To Introduce 2.0 Postbiotic
      • 13.3.1.3. Beliv Launches Mighty Pop, the First Soda with Pre-, Pro-, and Postbiotics

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Archer-Daniels-Midland Company
    • 14.1.2. Beekeepers Naturals Inc.
    • 14.1.3. Bioflag Group
    • 14.1.4. Cargill Incorporated
    • 14.1.5. Dr. Emil Nutrition
    • 14.1.6. DSM-Firmenich AG
    • 14.1.7. Essential Formulas Incorporated
    • 14.1.8. GeneFerm Biotechnology Co., Ltd.
    • 14.1.9. Gundry MD
    • 14.1.10. GutArmor by Get Wellness, LLC
    • 14.1.11. Healist Naturals, Inc
    • 14.1.12. Ildong Pharmaceutical Co., Ltd.
    • 14.1.13. Kerry Group PLC
    • 14.1.14. Kirin Holdings Company, Limited
    • 14.1.15. Lactobio A/S
    • 14.1.16. Maypro Group
    • 14.1.17. MCLS Europe B.V.
    • 14.1.18. MRM Nutrition
    • 14.1.19. Otemchi Biotechnologies Pte. Ltd.
    • 14.1.20. Phileo by Lesaffre
    • 14.1.21. Postbiotics Inc.
    • 14.1.22. Probiotics Australia Pty., Ltd.
    • 14.1.23. Probioway Co., Ltd.
    • 14.1.24. Sabinsa Corporation
    • 14.1.25. Silab
    • 14.1.26. Symbiotec Laboratoire
    • 14.1.27. T.H.T. sa
    • 14.1.28. woresan GmbH
    • 14.1.29. POSTBIOTICA S.R.L.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing